InterSystems Makes HL7 FHIR® Integration Components Free to NHS Customers

InterSystemsInterSystems, a global leader in information technology platforms for health, business, and government applications, has committed to making all NHS HL7® FHIR® profiles available to NHS customers, as part of their long-standing commitment to interoperability.

FHIR is an international standard for exchanging information between systems, developed by HL7 International. It is being used alongside other standards in a number of national projects to support the structured exchange of information between IT systems.

HealthShare Health Connect integration platform already supports international HL7 FHIR Profiles, Jon Payne, manager, sales engineering at InterSystems, said: "Interoperability using the HL7 FHIR standard is the cornerstone around which the NHS will build the joined-up IT systems that it needs for integrated health and care."

InterSystems' continued commitment to the NHS means organisations using Health Connect will be able to take advantage of NHS FHIR profiles as they become available - at no additional cost.

"Any organisation with a supported version of Health Connect will be able to draw down these integration components free of charge. That means we will be providing free capabilities to organisations that have may otherwise have to pay for them elsewhere."

Amongst the components being made available is support for the Transfer of Care Initiative, which is promoting the use of standards to send discharge letters and outpatient clinic letters from hospitals to GPs, as well as support for GP Connect, which is supporting the exchange of GP clinical information with other systems. Specific components for other use cases such as Child Health, eReferrals and Care Connect will also be included in this initiative.

Given that the chosen transport mechanism from NHSD for FHIR message exchange is Message Exchange for Social Care and Health (MESH), an accredited MESH adapter is also freely available, which can be used as a stand-alone component to support trusts for other MESH messaging needs.

"InterSystems wholly supports these developments, which will make it quick and easy for them to benefit from the work we have done with others to get data flowing in support of patient care" he adds.

InterSystems has a history of supporting open initiatives in health and care. It was a founder member, and now with a co-chair representative, of the INTEROPen collaborative of suppliers, standards bodies and health organisations that has supported the creation, adoption and implementation of standards in healthcare.

It has built support for standards including HL7 FHIR into its product suite and is working on early-adopter and full roll-out projects for the NHS initiatives that use them. Both Transfer of Care and GP Connect are using the latest version of the HL7 FHIR standards which is supported by the latest release of Health Connect.

"We hope that through this development and collaboration we will provide a significant boost to interoperability" he confirms.

InterSystems customers who want to use the HL7 FHIR integration resources should contact their InterSystems representative. These products will be made available as curated content on request.

About InterSystems

InterSystems is the engine behind the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries. For more information, visit InterSystems.co.uk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...